Following the recent trend among Japanese firms, such as West Japan Railway, Tok...
FibroGen continues to face challenges in its clinical endeavors, now extending i...
AstraZeneca’s Andexxa has reached the endpoint of its study has made the decisi...
In a bid to combat respiratory syncytial virus (RSV) infections in older adults,...
Aridis Pharmaceuticals, Inc. received encouraging FDA feedback on their planned ...
Eli Lilly and Novo Nordisk, two major players in the pharmaceutical industry, ar...
Mirati had intended that its preliminary findings for sitravatinib would be used...
AstraZeneca announced favorable results for its Imfinzi and Lynparza combo in an...
Johnson & Johnson has reached another milestone in their competition with Bristo...
Bristol Myers’ Reblozyl has surpassed Epogen in treating anemia caused by myelod...
Sotagliflozin, a drug manufactured by Lexicon Pharmaceuticals (Lexicon) which is...
As global demand for the COVID-19 vaccine plummets, the European Union has decid...
Massachusetts-based biotech Moderna has shared results from its early clinical t...
The review of a highly anticipated gene therapy for Duchenne muscular dystrophy ...
The $300 million series A raised by ReNAgade Therapeutics has been surpassed by ...
Novo Nordisk has announced that an oral form of semaglutide, the medication mark...
